Superficial gastritis with moderate intestinal epithelialization requires early medical consultation and treatment, and the treatment plan includes anti-Helicobacter pylori treatment, symptomatic treatment and the treatment of heterotrophic hyperplasia.
1. Anti-Helicobacter pylori treatment: chronic superficial gastritis with moderate intestinal epithelial hyperplasia needs to exclude the possibility of Helicobacter pylori infection, and if there is an infection, it needs to be treated in time. The treatment program includes two antibiotics, a proton pump inhibitor, a bismuth agent, representative drugs are amoxicillin capsules, clarithromycin tablets, colloidal bismuth pectin capsules and pantoprazole sodium enteric-coated tablets.
2. Symptomatic treatment: chronic superficial gastritis with moderate intestinalization causes indigestion, acid reflux, heartburn, stomach pain and other symptoms, can be actively symptomatic treatment. Acid-suppressing drugs such as pantoprazole, omeprazole, rabeprazole, etc.; gastric power-promoting drugs such as mosapride; gastric mucosa protector drugs such as aluminum sulfate capsules and ranitidine tablets.
3. Treatment of heterotrophic hyperplasia: moderate to severe intestinal epithelial hyperplasia with atypical hyperplasia or intraepithelial neoplasia is a precancerous lesion, which should be highly valued, and it is recommended to follow up regularly, and endoscopic gastric mucous membrane resection or surgical treatment can be adopted for those whose condition has progressed.
When superficial gastritis with moderate intestinal epithelial hyperplasia is found, it should be treated as early as possible, and the specific medication should be consulted with the advice of professional physicians.